| Business Summary | | Naturewell,
Inc.,
formerly
known
as
La
Jolla
Diagnostics,
Inc.,
is
engaged
in
the
development
of
healthcare
and
diagnostic
products.
Through
its
subsidiary
DiagnosTech,
Inc.
the
Company
has
finished
work
on
its
most
significant
diagnostic
product,
a
rapid
diagnostic
test
for
active
Tuberculosis.
In
March
2000
the
company
licensed
this
TB
product
to
Meridian
Diagnostics,
Inc.
for
worldwide
marketing
and
distribution.
Sales
are
scheduled
to
begin
in
October
2000.
The
Company's
product
identifies
active
TB
quickly
accurately,
and
inexpensively.
The
Company
also
is
engaged
in
the
mass
marketing
of
its
nutraceutical
and
homeopathic
products,
which
are
formulated
using
proprietary
technology.
The
development
of
MigraSpray
and
AllerSpray
was
completed
this
year.
In
addition,
Naturewell
plans
to
begin
marketing
its
FDA
approved
NatureWell
Contact
Lenses
in
October
2000,
along
with
its
Living
Water
Eye
Lotion
and
Optopet
Eye
Wash. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Naturewell,
Inc.
is
engaged
in
the
development
and
marketing
of
proprietary
healthcare
products,
including
eye
drops,
nasal
sprays
and
nutraceutical
products.
The
Company
is
also
developing
rapid
diagnostic
tests.
For
the
nine
months
ended
3/31/01,
net
sales
fell
46%
to
$32
thousand.
Net
loss
totaled
$1.5
million,
up
from
$504
thousand.
Results
reflect
reduced
product
sales,
increased
personnel
expenses
and
a
$775
thousand
reserve
for
the
Company's
inventory
of
Antisera. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Donald Brucker, 67 Chairman,
Pres, CEO | $96K | Kenneth Yonika, 38 CFO | -- | Dollar
amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|